(a–b′) Displacement of Ena/VASP family proteins by the proline-rich repeats of ActA. HeLa cells were transfected with GFP-ActA repeats (a and a′) or with the mutant GFP-ActA repeats F > A (b and b′), fixed, and labeled with antibodies to VASP (a and b, VASP labeling; a′ and b′, GFP signal). In untransfected cells, VASP localizes to focal adhesions (a, arrows). In cells expressing the GFP-ActA repeats (a, asterisks), VASP is displaced from the focal adhesions. In contrast, cells transfected with the mutated ActA repeats (for instance, asterisks in b) show a normal VASP localization (b, arrows). (c–h′) Inhibition of F-actin accumulation at the interface between Jurkat T cells and anti-CD3–coated beads. Jurkat T cells were transfected with GFP-ActA repeats (c and c′) or with the mutant GFP-ActA repeats F > A (d and d′). Note the lack of actin accumulation at the T cell–bead interface and the reduced zone of contact between T cell and bead (c, arrow). Such actin accumulation is not affected in Jurkat T cells that were transfected with the mutated ActA repeats (d, arrow; c and d, fluorescent phalloidin; c′ and d′, GFP signal). (e–h′) The localization of Evl but not that of Fyb/SLAP, WASP, and the Arp2/3 complex at the T cell–bead interface is affected by the proline-rich repeats of ActA. Jurkat T cells were transfected with GFP-ActA repeats, incubated with anti-CD3–coated beads, fixed, and labeled with antibodies to Evl (e), Fyb/SLAP (f), WASP (g), and Arp3 (h) (e′–h′, GFP signal). In cells expressing the GFP-ActA repeats, Evl is displaced from the T cell–bead contact sites (e, arrow). In contrast, the localization of Fyb/SLAP, WASP, and the Arp2/3 complex is unaffected. Bars: 10 μm (a–b′); and 5 μm (c–h′).